Clinical trials
Phase 3 trials in Moldova
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 7 |
| 2015 | 7 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 8 |
| 2020 | 12 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 9 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 56 |
| Terminated | 11 |
| Active, not recruiting | 10 |
| Recruiting | 9 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 8 |
| Biogen | 5 |
| Octapharma | 4 |
| Sanofi | 4 |
| Can-Fite BioPharma | 3 |
| UCB Biopharma SRL | 3 |
| Amgen | 2 |
| Arena Pharmaceuticals | 2 |
| Boehringer Ingelheim | 2 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 11 |
| Multiple Sclerosis, Relapsing-Remitting | 9 |
| Colitis, Ulcerative | 8 |
| Crohn Disease | 6 |
| Arthritis, Rheumatoid | 4 |
| Epilepsy | 4 |
| Hemophilia A | 3 |
| Hemophilia B | 3 |
| Hepatitis D | 3 |
| Recurrence | 3 |
Trials
Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.